Strategy reduced nephropathy risky by 21% in patients with type 2 diabetes, study finds. Intensive glucose control with gliclazide (modified release) and other agents reduced the risk of nephropathy ...

Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg – far below the standard guidelines of 140 mmHg – to reduce the risk of heart disease in ...

This carefully designed meta-analysis combined results from 5 recent clinical trials to shed further light on the confusing question of whether intensive glycemic control reduces the risk for ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

A new study by researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood pressure control continues to significantly reduce the risk of mild cognitive ...

Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year. "The public health impact of adopting intensive treatment in the ...

SAN FRANCISCO, CA—In the SPRINT trial, patients who were treated to an intensive versus standard blood pressure goal had a lower risk of developing LV conduction disease, which hasn’t been considered ...

Targeting a systolic blood pressure below 130 mm Hg was associated with a 21% decreased risk of all-cause mortality among patients with stage 3 to 4 chronic kidney disease, a meta-analysis found. An ...

Please provide your email address to receive an email when new articles are posted on . In patients who had endovascular thrombectomy for acute ischemic stroke with large-vessel occlusion, intensive ...

Patients randomized to an intensive control target of 90-130 mg/dL ended up with a similar mean glucose compared with those assigned a standard 140-180 mg/dL treatment target (170 vs 175 mg/dL, P=0.25 ...